L'Allopurinolo in Urologia(*): Nota 1a *

Alexander S. , Brendler H. : Treatment of uric acid urolithiasis with allopurinol: a xantine-oxidase inhibitor. J. Urol., 97: 340: 1967.

Anderson E. E. , Rundles R. W. , Silberman H. H. , Metz E. N. : Allopurinol control of hyperuricosuria: a new concept in the prevention of uric acid stones. J. Urol., 97: 344: 1967.

Elion G. B. , Callahan S. W. , Nathan H. , Bieber S. , Rundles R. W. , Hitchings G. H. : Potentiation by inhibition of drug degradation: 6–substituted purines and xanthine-oxidase. Biochem. Pharmacol., 12: 85: 1963.

Havez C. P. , Metz E. N. , Robinson R. R. , Rundles R. W. : Use of allopurinol to control hyperuricemia in patients on chronic intermittent hemodialisis. Trans. Amer. Soc. Artif. Intern. Organs, 11: 247: 1965.

Levin N. V. , Abrahams O. L. : Allopurinol in patients with impaired renal function. Ann. rheum. Dis., 25 suppl., 681: 1966.

Marcolongo R. Jr. , Carcassi A. , Lunghetti R. , Bravi A. , Bianco G. , Di Paolo N. : L'allopurinolo nel trattamento delle iperuricemie primitive e secondarie. Metabolismo, 3: 593: 1967.

Ogryzlo M. A. , Urowitz M. B. , Weber H. M. , Houpt J. B. : Effects of allopurinol on gouty and non gouty uric acid nephropaty. Ann. rheum. Dis., 26 suppl., 673: 1966.

Richet M. G. , Crosnier J. , Lagrue G. , Legrain M. , Méry J. Ph. , Hamburger J. : Peut-on aujourd'hui se faire une idée claire des rapports entre la goutte et les néphropaties? Presse méd., 75: 529: 1966.

Rundles R. W. (a): Metabolic effects of allopurinol and alloxanthine. Ann. rheum. Dis., 25 suppl., 615: 1966.

Rundles R. W. (b): Allopurinol in gouty nephropaty and renal dialisis. Ann. rheum. Dis., 25 suppl., 694: 1966.

Rundles R. W. , Silberman H. R. , Hitchings G. H. , Elion G. B. (a): Effects of xanthine-oxidase inhibitor on clinical manifestation and purine metabolism. Ann. int. Med., 60: 717: 1964.

Rundles R. W. , Metz E. N. , Silberman H. R. (b): Allopurinol in the treatment of gout. Ann. int. Med., 64: 229: 1966.

Rundles R. W. , Elion G. B. , Hitchings G. H.(c) : Allopurinol in the treatment of gout and secondary hyperuricemia. Bull. rheum. Dis., 16: 400: 1966.

Scott J. T. , O'brien P. K. : Probenecid nephrotic syndrome and renal failure. Ann. rheum. Dis., 27: 249: 1968.

Sjöberg K. H. : Allopurinol therapy of gout with renal complications. Ann. rheum. Dis., 25 suppl., 688: 1966.

Sokoloff L. : Pathology of gout. Metabolism, 6: 230: 1957.

Talbott J. H. , Terplan K. L. : The kidney in gout. Medicine, 39: 405: 1966.

Vries (de) A. , Frank M. , Liberman U. A. , Sperling O. : Allopurinol in the prophylaxis of uric acid stones. Ann. rheum. Dis., 25 suppl., 691: 1966.

Yü T. F. , Gutman A. B. : Effect of allopurinol on serum and urinary uric acid in primary and secondary gout. Amer. J. Med., 37: 885: 1964.